Asthma 'Of Mice and Men'-How do animal models help us understand human asthma?
1994; Wiley; Volume: 24; Issue: 1 Linguagem: Inglês
10.1111/j.1365-2222.1994.tb00909.x
ISSN1365-2222
Autores Tópico(s)Allergic Rhinitis and Sensitization
ResumoClinical & Experimental AllergyVolume 24, Issue 1 p. 6-9 Free Access Asthma ‘Of Mice and Men’–How do animal models help us understand human asthma? R. Djukanović, R. Djukanović Immunopharmacology Group, University Medicine, Centre Block, Level D. Southampton General Hospital, Southampton SO9 4XY, UK.Search for more papers by this author R. Djukanović, R. Djukanović Immunopharmacology Group, University Medicine, Centre Block, Level D. Southampton General Hospital, Southampton SO9 4XY, UK.Search for more papers by this author First published: January 1994 https://doi.org/10.1111/j.1365-2222.1994.tb00909.xCitations: 5AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Djukanović R, Roche WR. Wilson JW et al. Mucosal inflammation in asthma. State of the art. Am Rev Respir Dis 1990; 142: 434– 57. 2 Kirby JG, Hargreave FE, Gliech GJ, O'Byrne PM. Bron-choalveolar cell profiles of asthmatic and nonasthmatic subjects. Am Rev Respir Dis 1987; 136: 379– 83. 3 Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989; 139: 806– 17. 4 Djukanović R, Lai CKW, Wilson JW et al. Bronchial mucosal manifestations of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic nonasth-maties and healthy controls. Eur Respir J 1992; 5: 538– 44. 5 Montefort S, Djukanović R, Holgate ST, Roche WR. Ciliated cell damage in the bronchial epithelium of asthmatics and non-asthmatics. Clin Exp Allergy 1993; 23: 185– 9. 6 Bradley BL, Azzawi M, Jacobson M et al. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 1991; 88: 661– 74. 7 Lozewicz S, Gomez E, Ferguson H, Davies RJ. Inflammatory cells in the airways in mild asthma. Br Med J 1988; 297: 1515– 6. 8 Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics: characterisation, clinical and physiological correlations. Lancet 1989; 1: 520– 4. 9 Djukanovic R, Wilson JW, Britten KM, Wilson SJ, Walls AF. Howarth PH, Holgate ST. Quantitation of mast cells and cosinophils in the bronchial mucosa of atopic asthmatics and healthy control subjects using immunohisto-chemistry. Am Rev Respir Dis 1990; 152: 863– 71. 10 Wilson JW, Djukanović R, Howarth PH, Holgate ST. Lymphocyte activation in bronchoalveolar lavage and peripheral blood in atopic asthma. Am Rev Respir Dis 1992; 145: 958– 60. 11 Robinson DS, Hamid Q, Ying S et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Mod 1992; 326: 298– 304. 12 Flint KC, Leung KBP, Hudspith BN et al. Bronchoalveolar mast cells in extrinsic asthma: a mechanism for the initiation of antigen specific bronchoconstriction. Br Med J 1985; 291: 923– 6. 13 Casale TB, Wood D, Richeroson HB et al. Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial responsiveness. J Clin Invest 1987; 79: 1197– 203. 14 Marsh WR, Irvin CG, Murphy KR, Behrens BL, Larsen GL. Increases in airway hyperreactivity to histamine and inflammatory cells in bronchoalveolar lavage after the late asthmatic response in an animal model. Am Rev Respir Dis 1985; 131: 875– 9. 15 Webber SE, Widdicombe JG. The transport of albumin across the ferret in-vitro whole trachea. J Physiol 1989; 408: 457– 72. 16 Laitinen LA, Robinson NP, Laitinen A, Widdicombe JG. Relationship between tracheal mucosal thickness and vascular resistance in dogs. J Appl Physiol 1986; 61: 2186– 93. 17 Allegra L, Abraham WM, Chapman GA, Wanner A. Duration of mucociliary dysfunction following allergen challenge in allergic sheep. J Appl Physiol 1983; 55: 726– 30. 18 Irvin CG, Baltopoulos G, Honour J, Seccombe JF, Henson MM. Lipid mediators released by activated human neutrophils which increase airways reactivity. Am Rev Respir Dis 1986; 133(abstr): 175. 19 Gleich GJ, Frigas E, Loegering DA, Wassom DL, Stein-muller D. Cytotoxic properties of the eosinophil major basic protein. J Immunol 1979; 123: 2925– 7. 20 Gundel RH, Letts GL, Gleich GJ. Human eosinophil major basic protein induces airway constriction and airway hyper-responsiveness in primates. J Clin Invest 1991; 87: 1470– 3. 21 Murphy KR, Wilson MC, Irvin CG, Glezen LS, Marsh WR, Haslett C, Henson PM, Larsen GL. The requirement for polymorphonuclear leukocytes in the late asthmatic response and heightened airways reactivity in an animal model. Am Rev Respir Dis 1986; 134: 62– 8. 22 Frigas E, Loegering DA, Solley GO, Farrow GM, Gleich GJ. Elevated levels of eosinophil granule major basic protein in the sputum of patients with bronchial asthma. Mayo Clin Proc 1981; 56: 345– 53. 23 Brusselle GG, Kips JC, Tavernier JH et al. Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin Exp Allergy 1994; 24: 73– 80. 24 Gerblich AA, Campbell AE, Schuyler MR. Changes in T-lymphocyte subpopulations after antigenic bronchial provocation in asthmatics. N Engl J Med 1984; 310: 1349– 52. 25 Gerblich AA, Hannah S, Schluyer MR. Dynamic T-cell changes in peripheral blood and bronchoalveolar lavage after antigen bronchoprovocation in asthmatics. Am Rev Respir Dis 1991; 143: 533– 7. 26 Romagnani S. Induction of Th1 and Th2 responses: a key role for ‘natural’ immune response Immunol Today 1992; 13: 379– 381. 27 Gajewski TF, Joyce J, Fitch FW. Antiproliferative effect of interferon-γ in immune regulation. III. Differential selection of Thl and Th2 murine helper T lymphocyte clones using recombinant IL-2and rccombinant IFN-γ. J Immunol 1989; 143: 15– 20. 28 Fiorentino D, Bond HW, Mossmann TR. Two types of mouse T helper cells. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 65– 80. 29 Parronchi P, Tiri A, Macchia D et al. Noncognate contact-dependent B cell activation can promote IL-4-dependent in vitro human IgE synthesis. J Immunol 1990; 144: 2102– 8. 30 Wierenga EA, Snoek M, Jansen HM, Bos JD, Van Lier RAW, Kapsenberg ML. Human atopen-specific types 1 and 2 T helper cell clones. J Immunol 1991; 147: 2942– 9. 31 Wierenga EA, Snoek M, De Groot C et al. Evidence for compartmentalization of functional subsets of CD4+ T lymphocytes in atopic patients. J Immunol 1990; 144: 4651– 6. 32 O'Hehir RE, Bal V, Quint D et al. An in vitro model of allergen-dependent IgE synthesis by human B lymphocytes: comparison of the response of an atopic and a non-atopic individual to Dermatophagoides spp. (house dust mite). Immunology 1989; 66: 499– 504. 33 Van Reijsen FC, Bruijnzeel-KoomenCAFM, Kalthoff FS et al. Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol 1992; 90: 184– 92. 34 Maggi E, Biswas P, Del Prete G et al. Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J Immunol 1991; 146: 1169– 74. 35 Lecossier D, Valeyre D, Loiseau A, Battesti J-P, Soler P, Hance AJ. T-lymphocytes recovered by bronchoalveolar lavage from normal subjects and patients with sarcoidosis are refractory to proliferative signals. Am Rev Respir Dis 1988; 137: 592– 9. 36 Hamid Q, Azzawi M, Ying S et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991; 87: 1541– 6. 37 Kay AB, Ying S, Varney V et al. Messenger RNA expression of the cytokine gene cluster IL-3, IL-4, IL-5 and GM-CSF in allergen-induced late phase cutaneous reactions in atopic subjects. J Exp Med 1991; 173: 775– 8. 38 Bentley AM, Meng Q, Robinson DS et al. Increases in activated T lymphocytes, eosinophils and cytokine messenger RNA for IL-5 and GM-CSF in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Resp Cell Mol Biol 1993; 8: 35– 42. 39 Tsuji K, Nakahata T, Takagi M et al. Effects of interleukin 3 and interleukin 4 on the development of ‘connective tissue type’ mast cells: Interleukin 3 supports their survival and interleukin 4 triggers and supports their proliferation syner-gistically with interleukin 3. Blood 1990; 75: 421– 27. 40 Favre C, Sealand S, Caux C, Duvert V, De Vries JE. Interleukin 4 has basophilic and eosinophilic growth-promoting activity on cord blood cells. Blood 1990; 75: 67– 73. 41 Irani A-M A, Craig SS, De Blois G et al. Deficiency of the tryptase positive, chymasc negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function. J Immunol 1987; 138: 4381– 6. 42 Hamaguchi Y, Kanakura Y, Fujita J, Takeda SI. Nakano T, Seiichiro T, Honjo T, Kitamura Y. Interleukin 4 as an essential factor for in vitro clonal growth of marine connective tissue-type mast cells. J Exp Med 1987; 165: 268– 73. 43 Twentyman OP, Finnerty JP, Holgate ST. The inhibitory effect of nebulised albulerol on the early and late phase reactions and increase in airway responsiveness provoked by inhaled allergen in asthma. Am Rev Respir Dis 1991; 144: 782– 7. 44 Bradding P, Feather IH, Howarth PH. Mueller R, Roberts JA, Britten K, Bews JPA, Hunt TC, Okayama Y, Hcusscr CH. Bullock GR, Church MK, Holgate ST. Interleukin 4 is localised to and released by human mast cells. J Exp Med 1992; 176: 1381– 6. 45 Bradding P, Feather IH, Wilson S et al. Immunolocalisation of cytokines in the nasal mucosa of normal and perennial rhinitic subjects: the mast cell as a source of IL-4, IL-5 and IL-6 in human allergic inflammation. J Immunol 1993; 151: 3853– 65. 46 Bradding P, Roberts JA, Britten KM et al. Intcrlcukins (IL)-4, -5, -6, and TNFα in normal and asthmatic airways: evidence for the human mast cell as an important source of these cytokines. Am J Respir Cell Mol Biol (in press). 47 Djukanovic R, Wilson JW, Britten KM et al. The effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 1992; 145: 669– 74. 48 Wilson JW, Djukanovic R, Howarth PH, Holgate ST. Inhaled beclomethasone dipropionate down-regulates airway lymphocyte activation in atopic asthma. Am Rev Respir Dis 1993; (in press). 49 Robinson DS, Hamid Q, Ying S et al. Prednisolonc treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5 and interferon-gamma cytokine gene expression. Am Rev Respir Dis 1993; 148: 401– 6. Citing Literature Volume24, Issue1January 1994Pages 6-9 ReferencesRelatedInformation
Referência(s)